| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |